These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3784305)

  • 21. Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
    Lin JL; Leu ML
    Nephrol Dial Transplant; 1996 Sep; 11(9):1891-3. PubMed ID: 8918652
    [No Abstract]   [Full Text] [Related]  

  • 22. Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency.
    Davis GR; Zerwekh JE; Parker TF; Krejs GJ; Pak CY; Fordtran JS
    Gastroenterology; 1983 Oct; 85(4):908-16. PubMed ID: 6688402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of calcium carbonate and aluminum hydroxide on human intestinal function.
    Saunders D; Sillery J; Chapman R
    Dig Dis Sci; 1988 Apr; 33(4):409-13. PubMed ID: 3349887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.
    Ogata H; Koiwa F; Shishido K; Kinugasa E
    Ther Apher Dial; 2005 Feb; 9(1):11-5. PubMed ID: 15828900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of aluminum hydroxide on the parathyroid-vitamin D axis of postmenopausal women.
    Villa ML; Packer E; Cheema M; Holloway L; Marcus R
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1256-61. PubMed ID: 1955506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium carbonate as a phosphate binder in hemodialysis patients.
    Taber TE; Hegemen TF; York S
    ASAIO Trans; 1986; 32(1):127-9. PubMed ID: 3778697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of calcium carbonate and aluminium hydroxide as phosphate binders on biochemical bone markers, PTH(1-84), and bone mineral content in dialysis patients.
    Jespersen B; Jensen JD; Nielsen HK; Lauridsen IN; Andersen MJ; Poulsen JH; Gammelgaard B; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(2):98-104. PubMed ID: 1857534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
    Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
    Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium carbonate as a phosphate binder in children on continuous ambulatory peritoneal dialysis and hemodialysis.
    Sieniawska M; Roszkowska-Blaim M; Weglarska J; Jabłczyńska A; Welc-Dobies J
    Mater Med Pol; 1991; 23(3):203-8. PubMed ID: 1842716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables.
    Recker RR; Saville PD
    J Lab Clin Med; 1971 Sep; 78(3):380-8. PubMed ID: 5092859
    [No Abstract]   [Full Text] [Related]  

  • 32. Calcium supplements and milk: effects on acid-base balance and on retention of calcium, magnesium, and phosphorus.
    Lewis NM; Marcus MS; Behling AR; Greger JL
    Am J Clin Nutr; 1989 Mar; 49(3):527-33. PubMed ID: 2923085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium carbonate as a phosphate binder in dialysis patients: evaluation of an enteric-coated preparation and effect of additional aluminium hydroxide on hyperaluminaemia.
    Ittel TH; Schäfer C; Schmitt H; Gladziwa U; Sieberth HG
    Klin Wochenschr; 1991 Jan; 69(2):59-67. PubMed ID: 2027271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis: calcium, fluoride, and aluminum interactions.
    Spencer H; Kramer L
    J Am Coll Nutr; 1985; 4(1):121-8. PubMed ID: 3886758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence in favor of a severely impaired net intestinal calcium absorption in patients with (early-stage) chronic kidney disease.
    Viaene L; Meijers BK; Vanrenterghem Y; Evenepoel P
    Am J Nephrol; 2012; 35(5):434-41. PubMed ID: 22538635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of calcium carbonate as an intestinal chelator of phosphorus].
    Bongiorno P; Caligaris F; Montalcini G; Biamino E; Imarisio P; Dagna L; Arnaud A
    Minerva Urol Nefrol; 1990; 42(1):55-7. PubMed ID: 2389224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aluminum and magnesium burden of dialysis patients using antacids. A comparative study].
    Eichhorn M
    Fortschr Med; 1989 Aug; 107(23):502-6. PubMed ID: 2670719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aluminum hydroxide on fluoride metabolism.
    Spencer H; Kramer L; Norris C; Wiatrowski E
    Clin Pharmacol Ther; 1980 Oct; 28(4):529-35. PubMed ID: 7408412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function.
    Heinrich T; Heidt H; Hafner V; Schmidt-Gayk H; Jenetzky E; Walter-Sack I; Mikus G; Bommer J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2861-7. PubMed ID: 18388122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.